Re-reading announcements:
Q-When will the first patients be treated with Zantrene to protect their hearts during
chemotherapy?
"The aim is to treat the first breast cancer patient with Zantrene soon after the new
formulation has been manufactured and is ready for use in clinical trials – Race expects
this to occur in Q3 2023 (ASX Announcement: 28 September 2022)."
General Comments / Chat, page-8355
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.035(2.66%) |
Mkt cap ! $224.4M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.38 | $1.32 | $123.2K | 91.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13546 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 782 | 2 |
View Market Depth
| Last trade - 14.29pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.38 |
Change
0.035 ( 7.81 %) |
||||
| Open | High | Low | Volume | ||
| $1.34 | $1.38 | $1.32 | 13096 | ||
| Last updated 14.50pm 10/05/2024 ? | |||||
| RAC (ASX) Chart |